Cargando…
Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions
PURPOSE: To determine the patient-centered effectiveness of switching patients with persistent macular edema due to retinal vein occlusion (RVO) to aflibercept using the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25). MATERIALS AND METHODS: Prospective study of eyes with persis...
Autores principales: | Spooner, Kimberly, Fraser-Bell, Samantha, Hong, Thomas, Chang, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493984/ https://www.ncbi.nlm.nih.gov/pubmed/34703739 http://dx.doi.org/10.4103/tjo.tjo_19_20 |
Ejemplares similares
-
Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion
por: Spooner, Kimberly, et al.
Publicado: (2020) -
Optical-coherence tomography angiography and ultrawide-field angiography findings in eyes with refractory macular edema secondary to retinal vein occlusion switched to aflibercept: A subanalysis from a 48-week prospective study
por: Spooner, Kimberly, et al.
Publicado: (2020) -
Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors
por: Spooner, Kimberly, et al.
Publicado: (2019) -
Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
por: Braimah, Imoro Z, et al.
Publicado: (2019) -
12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry
por: Niedzwiecki, Mateusz, et al.
Publicado: (2021)